Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study

被引：49
|
作者：
Stopeck, A. [1 ]
Body, J. J. [2 ]
Fujiwara, Y. [3 ]
Lipton, A. [4 ]
Steger, G. G. [5 ]
Viniegra, M. [6 ]
Fan, M. [7 ]
Braun, A. [8 ]
Dansey, R. [8 ]
Jun, S. [8 ]
机构：
[1] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA
[2] Univ Libre Bruxelles, CHU Brugmann, Brussels, Belgium
[3] Natl Canc Ctr, Tokyo, Japan
[4] Penn State Milton S Hershey Med Ctr, Hershey, PA USA
[5] Med Univ Vienna, Vienna, Austria
[6] Corp Med Gen San Martin, San Martin, Argentina
[7] Amgen Inc, Biostat & Epidemiol, Thousand Oaks, CA 91320 USA
[8] Amgen Inc, Hematol Oncol, Thousand Oaks, CA 91320 USA
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(09)72028-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2 / 3
页数：2
相关论文
共 50 条
  • [21] Randomized trial of denosumab versus zoledronic acid in prostate cancer patients with bone metastases and elevated bone turnover markers after receiving zoledronic acid therapy
    Bosserman, Linda
    Fizazi, Karim
    Lipton, Allan
    Rahim, Yasmin
    Suarez, Tirzo
    Fan, Michelle
    Wu, Ling
    Markus, Richard A.
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 335 - 336
  • [22] Denosumab versus zoledronic acid (ZA) for the treatment of bone metastases: An integrated analysis of results from 2 randomized, double-blind, phase 3 trials
    Lipton, A.
    Stopeck, A.
    von Moos, R.
    Henry, D.
    Richardson, G.
    Rodriguez, G.
    Bourgeois, H.
    Ke, C.
    Jun, S.
    Dansey, R.
    [J]. BONE, 2011, 48 (01) : S21 - S21
  • [23] Denosumab and zoledronic acid treatment in patients with genitourinary cancers and bone metastases
    Costa, Luis
    Fizazi, Karim
    Saad, Fred
    Brown, Janet Elizabeth
    Von Moos, Roger
    Oudard, Stephane
    Sternberg, Cora N.
    Ganju, Vinod
    Miller, Kurt
    Wang, Huei
    Maniar, Tapan
    Braun, Ada
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] A COMPARISON OF DENOSUMAB VERSUS ZOLEDRONIC ACID FOR THE PREVENTION OF SKELETAL-RELATED EVENTS IN BREAST CANCER PATIENTS WITH BONE METASTASES
    Fujiwara, Yasuhiro
    Stopeck, Alison
    de Boer, Richard
    Lichinitser, Mikhail
    Tonkin, Katia
    Yardley, Denise
    Fan, Michelle
    Jiang, Qi
    Jun, Susie
    Dansey, Roger
    Braun, Ada
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 12 - 12
  • [25] A Comparison of Denosumab Versus Zoledronic Acid for the Prevention of Skeletal-Related Events in Breast Cancer Patients with Bone Metastases
    Stopeck, A.
    de Boer, R.
    Fujiwara, Y.
    Lichinitser, M.
    Tonkin, K.
    Yardley, D.
    Fan, M.
    Jiang, Q.
    Jun, S.
    Dansey, R.
    Braun, A.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 490S - 490S
  • [26] Cost-Effectiveness of Denosumab Compared With Zoledronic Acid in Patients With Breast Cancer and Bone Metastases
    Xie, Jipan
    Diener, Melissa
    Sorg, Rachael
    Wu, Eric Q.
    Namjoshi, Madhav
    [J]. CLINICAL BREAST CANCER, 2012, 12 (04) : 247 - 258
  • [27] DENOSUMAB IS SUPERIOR TO ZOLEDRONIC ACID FOR DELAYING OR PREVENTING SKELETAL RELATED EVENTS (SRES) IN BREAST CANCER PATIENTS WITH BONE METASTASES (BM): RESULTS OF A PHASE 3 TRIAL
    Body, J.
    Stopeck, A.
    Fujiwara, Y.
    Lipton, A.
    Steger, G. G.
    Viniegra, M.
    Fan, M.
    Dansey, R.
    Jun, S.
    Braun, A.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 60 - 60
  • [28] PAIN IN PATIENTS WITH METASTATIC BREAST CANCER: RESULTS FROM A PHASE III TRIAL OF DENOSUMAB VERSUS ZOLEDRONIC ACID
    de Boer, R. H.
    Stopeck, A.
    Fallowfield, L.
    Patrick, D.
    Cleeland, C. S.
    Steger, G. G.
    Qian, Y.
    Dansey, R. D.
    Braun, A. H.
    Chung, K.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 40 - 40
  • [29] COMPARISON OF DENOSUMAB VERSUS ZOLEDRONIC ACID (ZA) FOR TREATMENT OF BONE METASTASES IN ADVANCED CANCER PATIENTS: AN INTEGRATED ANALYSIS OF 3 PIVOTAL TRIALS
    Lipton, A.
    Siena, S.
    Rader, M.
    Bilynskyy, B.
    Viniegra, M.
    Richardson, G.
    Beuzeboc, P.
    Clemens, M.
    Ke, C.
    Jun, S.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 380 - 380
  • [30] Safety of Denosumab Versus Zoledronic Acid in Patients with Bone Metastases: A Meta-Analysis of Randomized Controlled Trials
    Chen, Fengxia
    Pu, Feifei
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (7-8) : 453 - 459
12345